Predictive And Prognostic Value Of Hepatic Steatosis In Conversion Therapy For Colorectal Liver-limited Metastases: A Propensity Score Matching Analysis

PURPOSE: To evaluate the role of hepatic steatosis (HS) in patients with synchronous colorectal liver-limited metastases (CLLMs) undergoing conversion therapy. PATIENTS AND METHODS: From March 2013 to March 2017, a total of 406 patients with initially unresectable CLLMs accepted conversion therapy i...

Descripción completa

Detalles Bibliográficos
Autores principales: Jian, Mi, Chang, Wenju, Ren, Li, Liu, Tianyu, Chen, Yijiao, Wei, Ye, Lin, Qi, Xu, Jianmin, Qin, Xinyu
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove 2019
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750205/
https://www.ncbi.nlm.nih.gov/pubmed/31571989
http://dx.doi.org/10.2147/CMAR.S210185

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6750205/
https://www.ncbi.nlm.nih.gov/pubmed/31571989
http://dx.doi.org/10.2147/CMAR.S210185

Ejemplares similares